Clinical Trial

Masseter Muscle Thickness in Gasser Ganglion Radiofrequency Treatment

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 5, 2025 (before its estimated July 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
Trigeminal neuralgia is common painful disorder in pain medicine clinics. Gasserian ganglion radiofrequency thermocoagulation is one of the treatment option in patients with trigeminal neuralgia in refractory cases. The most commonly involved branch in trigeminal neuralgia is the mandibular branch. Masseter muscle is innervated by mandibulary nerve branch of the trigeminal nerve. The radiofrequency thermocoagulation therapy is used to ablate the affected trigeminal nerve branch and some of patients complain of subjective masseter weakness after this procedure. In theoretical basis, muscles innervated by target nerve are affected from ablation procedure. In this study the primary aim is to evaluate the change of the masseter muscle thickness in patients treated by gasserian ganglion radiofrequency thermocoagulation. The results may also show possible functional effect of the procedure related with masseter muscle.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-02-22.
Status change: Not Yet Recruiting → Recruiting 2025-03-03
Trial Details
NCT Number NCT06278194
Lead Sponsor Başakşehir Çam & Sakura City Hospital
Conditions Trigeminal Neuralgia, Gasserian Ganglion; Lesion
Enrollment 30 participants
Start Date 2024-03-15
Primary Completion 2025-07-15 (estimated)
Study Completion 2025-10-15 (estimated)
Updated on ClinicalTrials.gov 2025-03-05